Singapore, May 29, 2025 — Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”) has reaffirmed its strong financial health and strategic vision, despite recent fluctuations in its stock value.
Dr. Darren Chhoa, CEO of BMGL, speaking for the Board and management, stated, “While recent stock price movements may cause concern, I want to reassure shareholders and stakeholders that BMGL’s fundamentals remain robust. Our financial performance is strong, with subsidiaries securing significant new contracts, particularly in the supply chain, and we are on track with our acquisition strategy.”
“We believe the recent stock price decline doesn’t reflect the true value of our business or the progress we’ve made. BMGL has consistently demonstrated strong operations, responsible capital management, and a commitment to creating lasting value for shareholders.”
About Basel Medical Group Ltd
Basel Medical, based in Singapore, provides orthopedic and trauma care, sports medicine and surgery, orthopedic procedures, and neurosurgical treatments. Our clinics are located at 6 Napier Road, Unit #02-10/11 and Unit #03-07, Gleneagles Medical Centre, Singapore. Over the past 20 years, we’ve developed strong relationships with many corporations, especially in construction, marine, and oil & gas, supporting our business model. As a Singaporean orthopedic service provider with over 20 years of experience, we are well-positioned to capitalize on growth opportunities in Singapore and Southeast Asia’s private healthcare sector, driven by aging populations, rising incomes, increased private insurance, government healthcare efforts and spending, growing sports participation, and Singapore’s status as a premium healthcare destination in Asia. Our management and medical team includes orthopedic and neurosurgery specialists, as well as corporate finance and healthcare partnership experts. Basel Medical Group Ltd is the holding company, conducting operations through Singapore-based subsidiaries. For details, visit www.baselmedical.com.
Forward-Looking Statements
This announcement contains forward-looking statements involving risks and uncertainties, based on current expectations and projections about future events affecting the Company’s financial condition, operations, strategy, and needs. These statements can often be identified by words like “aim,” “anticipate,” “believe,” “estimate,” “expect,” “going forward,” “intend,” “may,” “plan,” “potential,” “predict,” “propose,” “seek,” “should,” “will,” “would,” or similar expressions. The Company does not intend to update these statements to reflect new events or changes in expectations, except as required by law. While the Company believes these expectations are reasonable, it cannot guarantee their accuracy and advises investors that actual results may differ significantly and encourages them to review other factors in the Company’s SEC filings.
Media Contact:
Basel Medical Group Ltd
+65 6291 9188
“`
